2022 ACC/AHA coronary revascularization guidelines

A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with three-vessel disease and normal LV function. The panel provides a rebuttal on the benefits of CABG versus medical therapy and the reduction in class designation for CABG, as well as the use of the ISCHEMIA and other similar trials for drawing such comparative evidence conclusions.

Recent happenings and trends in mitral valve repair

In this series, Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a robotics program, and the importance of the mitral heart team.

2021 EACTS highlights

Listen in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Professor Bart Meuris of UZ Leuven in Belgium, and Professor Martin Andreas of the Medical University of Vienna discuss highlights from the 2021 EACTS annual conference.

Lifetime management of surgical aortic valve replacement patients

There are many options for the treatment for aortic valve disease. Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Joseph Bavaria from the Hospital of the University of Pennsylvania, Dr. Bob Kiaii from UC Davis Medical Center, and Dr. Maral Ouzounian from the Toronto General Hospital as they discuss the lifetime management of surgical aortic valve replacement patients.

Current practices and future state of coronary surgery

Hear an in-depth discussion on the current and future state of coronary surgery. This series is led by Professor Pieter Kappetein, who is joined by Dr. Marc Ruel of the Ottawa Heart Institute, Dr. John Puskas from Mount Sinai Morningside in New York, and Dr. Teresa Kieser from the University of Calgary. Together, they will provide insights into the progress, current trends, and the future of coronary surgery — covering topics that include the role of total arterial revascularization, minimally invasive approaches, and learning outside of the fellowship.

Diversity in healthcare

Listen to Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Kendra Grubb of Emory University, Dr. Vivek Rao of Toronto General, and Dr. J.W. Awori Hayanga of West Virginia University discuss the importance of diversity in healthcare. Hear what their institutions are doing to achieve it and the challenges they are overcoming along the way.

COVID and cardiac surgery — where are we now?

The COVID-19 pandemic has made a significant impact on cardiac surgery. Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, and Dr. Kendra Grubb of Emory University discuss how COVID-19 has affected their patients and practices, and how their institutions are moving forward.

Additional resources

Related pages

Education and training 

View our education and training materials for more information.